BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3724871)

  • 1. [Clinical significance of current perspectives in cholesterol metabolism].
    Stalenhoef AF; van 't Laar A
    Ned Tijdschr Geneeskd; 1986 May; 130(21):951-5. PubMed ID: 3724871
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of hyperlipoproteinaemia.
    Shepherd J; Packard CJ
    Scott Med J; 1986 Jul; 31(3):154-61. PubMed ID: 3798078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities of hepatic lipoprotein receptors.
    Havel RJ
    Annu Rev Physiol; 1986; 48():119-34. PubMed ID: 3010812
    [No Abstract]   [Full Text] [Related]  

  • 4. [The difficult road to cholesterol homeostasis].
    Joossens JV
    Verh K Acad Geneeskd Belg; 1984; 46(1):5-31. PubMed ID: 6331021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipoprotein receptor].
    Ishikawa T; Kagami A
    Nihon Rinsho; 1990 Nov; 48(11):2498-505. PubMed ID: 2176701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of lipoprotein and cholesterol metabolism in familial hypercholesterolemia].
    Wehr H
    Pol Arch Med Wewn; 1982; 67(1-2):47-52. PubMed ID: 7050936
    [No Abstract]   [Full Text] [Related]  

  • 7. A role for intracellular traffic of high-density lipoproteins in cholesterol metabolism.
    Willingham MC
    Lab Invest; 1989 Sep; 61(3):253-5. PubMed ID: 2770245
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasoprotection and vasoaggression - mode of action of lipoproteins].
    Mertz DP
    Med Klin Prax; 1982 Jun; 77(12):16-20. PubMed ID: 7110023
    [No Abstract]   [Full Text] [Related]  

  • 9. The low density lipoprotein receptor pathway in animals and man.
    Shepherd J; Packard CJ
    Health Bull (Edinb); 1982 Jul; 40(4):197-205. PubMed ID: 6288622
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptors in the regulation of lipoprotein metabolism.
    Packard CJ; Sheperd J
    Ann Biol Clin (Paris); 1988; 46(1):5-9. PubMed ID: 2839057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The four-legged hepatocyte: lessons learned about cholesterol metabolism from new technologies.
    Raper SE
    Hepatology; 1996 Aug; 24(2):463-5. PubMed ID: 8690422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles of cholesterol and bile acid metabolism in the liver and small intestine (II)].
    Stange EF
    Leber Magen Darm; 1986 Nov; 16(6):358-77. PubMed ID: 3807634
    [No Abstract]   [Full Text] [Related]  

  • 13. A receptor-mediated pathway for cholesterol homeostasis.
    Brown MS; Goldstein JL
    Science; 1986 Apr; 232(4746):34-47. PubMed ID: 3513311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Catabolism of low-density lipoproteins via receptors and its regulation].
    Mazière JC; Mazière C; Gardette J; Polonovski J
    Ann Biol Clin (Paris); 1986; 44(5):545-50. PubMed ID: 3544977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of cholesterol metabolism and the development of atherosclerosis].
    Pitsin D
    Vutr Boles; 1987; 26(5):16-23. PubMed ID: 2829445
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia.
    Bilheimer DW
    Beitr Infusionsther; 1988; 23():61-73. PubMed ID: 2484783
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholesterolaemia.
    Blaha M; Pecka M; Urbankova J; Blaha V; Maly J; Zadak Z; Blazek M
    Transfus Apher Sci; 2004 Apr; 30(2):83-7. PubMed ID: 15062743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay for LDL receptor activity].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():827-32. PubMed ID: 11351699
    [No Abstract]   [Full Text] [Related]  

  • 20. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.